{"id":12435,"date":"2015-03-11T15:20:02","date_gmt":"2015-03-11T14:20:02","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=12435"},"modified":"2015-03-11T15:20:02","modified_gmt":"2015-03-11T14:20:02","slug":"el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/es\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/","title":{"rendered":"El farmac\u00e9utico incrementa un 62% la adherencia a los tratamientos"},"content":{"rendered":"<p>La actuaci\u00f3n del farmac\u00e9utico desde la farmacia comunitaria <b>incrementa un 62% la adherencia al tratamiento de los pacientes<\/b>, seg\u00fan se desprende del \u201cEstudio sobre la adherencia y conocimiento del tratamiento con Inhibidores de la Bomba de Protones (IBP)\u201d, elaborado por el Consejo General de Colegios Oficiales de Farmac\u00e9uticos. Han participado 143 farmacias comunitarias de todo el territorio nacional (7 catalanas) que han seguido y evaluado a un total de 610 pacientes.<\/p>\n<figure id=\"attachment_12436\" aria-describedby=\"caption-attachment-12436\" style=\"width: 328px\" class=\"wp-caption alignleft\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2015\/03\/RIFAC1.jpg\"><img decoding=\"async\" class=\"wp-image-12436\" alt=\"RIFAC1\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2015\/03\/RIFAC1.jpg\" width=\"328\" height=\"141\" \/><\/a><figcaption id=\"caption-attachment-12436\" class=\"wp-caption-text\">La actuaci\u00f3n del farmac\u00e9utico produjo un aumento relativo del 62,2% en la tasa de cumplimiento del tratamiento por parte del paciente, registrando un porcentaje de adherencia del 78,5% al t\u00e9rmino del estudio frente al 48,4% de la visita inicial.<br \/>Fuente: Portalfarma (Consejo)<\/figcaption><\/figure>\n<p>Los resultados obtenidos en este estudio demuestran que, en pacientes que utilizaban IBP, la actuaci\u00f3n profesional del farmac\u00e9utico desde <b>la farmacia comunitaria aumenta significativamente el conocimiento de la medicaci\u00f3n por parte del paciente,<\/b> <b>el grado de adherencia al tratamiento, as\u00ed como una mejora de la calidad de vida de los pacientes<\/b>.<\/p>\n<p>El COFB ha colaborado en este estudio, que cuenta con el soporte de los laboratorios Cinfa.<\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"http:\/\/www.portalfarma.com\/Profesionales\/InvestigacionFarmacia\/Documents\/Estudio-sobre-conocimiento-adherencia-Inhibidores-Bomba-Protones.PDF\" target=\"_blank\" rel=\"noopener\"><div class=\"box shadow\"><span style=\"text-decoration: underline;\"><strong>Informe de los resultados del Estudio IBP<\/strong> (PDF)<\/span><\/a><\/p>\n<p>Fuente y m\u00e1s informaci\u00f3n: <span style=\"text-decoration: underline;\"><a href=\"http:\/\/www.portalfarma.com\/Profesionales\/Notas-de-prensa\/Paginas\/La-actuacion-del-farmaceutico-desde-la-Farmacia-comunitaria-incrementa-adherencia-al-tratamiento-de-pacientes.aspx\" target=\"_blank\" rel=\"noopener\"><strong>nota de prensa<\/strong> Portalfarma<\/a><\/span><\/p>\n<p><span style=\"text-decoration: underline;\"><a href=\"http:\/\/www.portalfarma.com\/profesionales\/investigacionfarmacia\/Paginas\/Investigacion-en-Farmacia.aspx\"><strong>Investigaci\u00f3n en Farmacia Comunitaria Red de Investigaci\u00f3n en Farmacia Comunitaria - RIFAC<\/strong> (v\u00eda Portalfrma)<\/a><\/span><\/div><\/p>","protected":false},"excerpt":{"rendered":"<p>La actuaci\u00f3n del farmac\u00e9utico desde la farmacia comunitaria incrementa un 62% la adherencia al tratamiento de los pacientes, seg\u00fan se desprende del \u201cEstudio sobre la adherencia y conocimiento del tratamiento con Inhibidores de la Bomba de Protones (IBP)\u201d, elaborado por el Consejo General de Colegios Oficiales de Farmac\u00e9uticos. Han participado 143 farmacias comunitarias de [\u2026]<\/p>","protected":false},"author":1,"featured_media":12447,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[32],"tags":[2187,64,45],"class_list":["post-12435","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticies-farmacia","tag-adherencia","tag-atencio-farmaceutica","tag-medicaments"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>El farmac\u00e8utic incrementa un 62% l\u2019adher\u00e8ncia als tractaments - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"El farmac\u00e8utic incrementa un 62% l\u2019adher\u00e8ncia als tractaments - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"L\u2019actuaci\u00f3 del farmac\u00e8utic des de la farm\u00e0cia comunit\u00e0ria incrementa un 62% l\u2019adher\u00e8ncia al tractament dels pacients, segons es despr\u00e8n del \u201cEstudi sobre l&#8217;adher\u00e8ncia i coneixement del tractament amb Inhibidors de la Bomba de Protons (IBP)\u201d, elaborat pel Consejo General de Colegios Oficiales de Farmac\u00e9uticos. Han participat 143 farm\u00e0cies comunit\u00e0ries de [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2015-03-11T14:20:02+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"El farmac\u00e8utic incrementa un 62% l\u2019adher\u00e8ncia als tractaments\",\"datePublished\":\"2015-03-11T14:20:02+00:00\",\"dateModified\":\"2015-03-11T14:20:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/\"},\"wordCount\":247,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"adher\u00e8ncia\",\"Atenci\u00f3 farmac\u00e8utica\",\"medicaments\"],\"articleSection\":[\"Not\u00edcies farm\u00e0cia\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/\",\"name\":\"El farmac\u00e8utic incrementa un 62% l\u2019adher\u00e8ncia als tractaments - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2015-03-11T14:20:02+00:00\",\"dateModified\":\"2015-03-11T14:20:02+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"El farmac\u00e8utic incrementa un 62% l\u2019adher\u00e8ncia als tractaments\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"El farmac\u00e8utic incrementa un 62% l\u2019adher\u00e8ncia als tractaments - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/","og_locale":"es_ES","og_type":"article","og_title":"El farmac\u00e8utic incrementa un 62% l\u2019adher\u00e8ncia als tractaments - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"L\u2019actuaci\u00f3 del farmac\u00e8utic des de la farm\u00e0cia comunit\u00e0ria incrementa un 62% l\u2019adher\u00e8ncia al tractament dels pacients, segons es despr\u00e8n del \u201cEstudi sobre l&#8217;adher\u00e8ncia i coneixement del tractament amb Inhibidors de la Bomba de Protons (IBP)\u201d, elaborat pel Consejo General de Colegios Oficiales de Farmac\u00e9uticos. Han participat 143 farm\u00e0cies comunit\u00e0ries de [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2015-03-11T14:20:02+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrito por":"wpAdminCofbOrg","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"El farmac\u00e8utic incrementa un 62% l\u2019adher\u00e8ncia als tractaments","datePublished":"2015-03-11T14:20:02+00:00","dateModified":"2015-03-11T14:20:02+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/"},"wordCount":247,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/#primaryimage"},"thumbnailUrl":"","keywords":["adher\u00e8ncia","Atenci\u00f3 farmac\u00e8utica","medicaments"],"articleSection":["Not\u00edcies farm\u00e0cia"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/","url":"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/","name":"El farmac\u00e8utic incrementa un 62% l\u2019adher\u00e8ncia als tractaments - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/#primaryimage"},"thumbnailUrl":"","datePublished":"2015-03-11T14:20:02+00:00","dateModified":"2015-03-11T14:20:02+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2015\/03\/11\/el-farmaceutic-incrementa-un-62-ladherencia-als-tractaments\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"El farmac\u00e8utic incrementa un 62% l\u2019adher\u00e8ncia als tractaments"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"L\u2019actuaci\u00f3 del farmac\u00e8utic des de la farm\u00e0cia comunit\u00e0ria incrementa un 62% l\u2019adher\u00e8ncia al tractament dels pacients, segons es despr\u00e8n del \u201cEstudi sobre l&#8217;adher\u00e8ncia i coneixement del tractament amb Inhibidors de la Bomba de Protons (IBP)\u201d, elaborat pel Consejo General de Colegios Oficiales de Farmac\u00e9uticos. Han participat 143 farm\u00e0cies comunit\u00e0ries de [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/12435","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/comments?post=12435"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/12435\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media?parent=12435"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/categories?post=12435"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/tags?post=12435"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}